Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 17 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

53%

9 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 4

7(43.8%)

N/A

6(37.5%)

Phase 3

2(12.5%)

Phase 2

1(6.3%)

16Total

Phase 4(7)

N/A(6)

Phase 3(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials

NCT05506865Phase 4Completed

Efficacy and Safety of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass Exposure

Role: lead

NCT06571942Phase 4Recruiting

Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure

Role: lead

NCT06531460Not ApplicableRecruiting

Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection

Role: lead

NCT06511284Not ApplicableRecruiting

Nutritional Therapy in Patients With Post-extubation Dysphagia

Role: lead

NCT06254001Phase 4Recruiting

Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects

Role: lead

NCT05243316Not ApplicableCompleted

Risk of Pneumothorax With and Without Chest Tube Clamping in Patients With Pleural Pathology

Role: lead

NCT05246293Phase 2Unknown

Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.

Role: lead

NCT05685641Not ApplicableUnknown

Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City

Role: lead

NCT05342558Phase 4Completed

Efficacy and Safety of ICS/LABA vs. LAMA/LABA in Patients With Different COPD Phenotypes.

Role: lead

NCT04315896Phase 3Completed

Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)

Role: lead

NCT04318015Phase 3Completed

Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)

Role: lead

NCT04894760Completed

Evaluation of a COVID-19 Rapid Diagnostic Test in ER Departments in Mexico: a Multi-center Study

Role: lead

NCT03154762Not ApplicableCompleted

Anti-inflammatory Effect of Nocturnal NIPPV on Acute Asthma

Role: lead

NCT02880735Not ApplicableUnknown

Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy

Role: lead

NCT02473237Phase 4Completed

Efficacy in Walked Distance of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass (EMERALD)

Role: lead

NCT01481727Phase 4Unknown

Exacerbation Prevention GOLD IV COPD With Non Invasive Mechanical Ventilation

Role: lead

NCT02345993Phase 4Unknown

Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis

Role: lead

All 17 trials loaded